412 related articles for article (PubMed ID: 35565273)
21. Preclinical Modelling of PDA: Is Organoid the New Black?
D'Agosto S; Andreani S; Scarpa A; Corbo V
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195689
[TBL] [Abstract][Full Text] [Related]
22. Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling.
Kim SK; Kim YH; Park S; Cho SW
Acta Biomater; 2021 Sep; 132():37-51. PubMed ID: 33711526
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring.
Mäkinen L; Vähä-Koskela M; Juusola M; Mustonen H; Wennerberg K; Hagström J; Puolakkainen P; Seppänen H
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158794
[TBL] [Abstract][Full Text] [Related]
24. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
[TBL] [Abstract][Full Text] [Related]
25. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities.
Yang J; Huang S; Cheng S; Jin Y; Zhang N; Wang Y
Front Cell Dev Biol; 2021; 9():701429. PubMed ID: 34409036
[TBL] [Abstract][Full Text] [Related]
26. Organoid and Spheroid Tumor Models: Techniques and Applications.
Gunti S; Hoke ATK; Vu KP; London NR
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
[TBL] [Abstract][Full Text] [Related]
27. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
28. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
Elife; 2020 Nov; 9():. PubMed ID: 33138918
[TBL] [Abstract][Full Text] [Related]
29. Disease Modeling in Stem Cell-Derived 3D Organoid Systems.
Dutta D; Heo I; Clevers H
Trends Mol Med; 2017 May; 23(5):393-410. PubMed ID: 28341301
[TBL] [Abstract][Full Text] [Related]
30. Tumor-on-a-chip: from bioinspired design to biomedical application.
Liu X; Fang J; Huang S; Wu X; Xie X; Wang J; Liu F; Zhang M; Peng Z; Hu N
Microsyst Nanoeng; 2021; 7():50. PubMed ID: 34567763
[TBL] [Abstract][Full Text] [Related]
31. Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?
Tran F; Klein C; Arlt A; Imm S; Knappe E; Simmons A; Rosenstiel P; Seibler P
Front Immunol; 2020; 11():573562. PubMed ID: 33408713
[TBL] [Abstract][Full Text] [Related]
32. Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review.
Medle B; Sjödahl G; Eriksson P; Liedberg F; Höglund M; Bernardo C
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565191
[TBL] [Abstract][Full Text] [Related]
33. Organoid development in cancer genome discovery.
Gao D; Chen Y
Curr Opin Genet Dev; 2015 Feb; 30():42-8. PubMed ID: 25796043
[TBL] [Abstract][Full Text] [Related]
34. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
[TBL] [Abstract][Full Text] [Related]
35. Progress and perspective of organoid technology in breast cancer research.
Huang C; Jin H
Chin Med J (Engl); 2024 Jan; ():. PubMed ID: 38185826
[TBL] [Abstract][Full Text] [Related]
36. Bioengineered Tumor Organoids.
Dominijanni A; Mazzocchi A; Shelkey E; Forsythe S; Devarsetty M; Soker S
Curr Opin Biomed Eng; 2020 Mar; 13():168-173. PubMed ID: 32432209
[TBL] [Abstract][Full Text] [Related]
37. Drug screening model meets cancer organoid technology.
Liu C; Qin T; Huang Y; Li Y; Chen G; Sun C
Transl Oncol; 2020 Nov; 13(11):100840. PubMed ID: 32822897
[TBL] [Abstract][Full Text] [Related]
38. On-chip anticancer drug screening - Recent progress in microfluidic platforms to address challenges in chemotherapy.
Dhiman N; Kingshott P; Sumer H; Sharma CS; Rath SN
Biosens Bioelectron; 2019 Jul; 137():236-254. PubMed ID: 31121461
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer organoids: models for preclinical research and precision medicine.
Liu Y; Zhou Y; Chen P
Front Oncol; 2023; 13():1293441. PubMed ID: 37941550
[TBL] [Abstract][Full Text] [Related]
40. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.
Skardal A; Shupe T; Atala A
Drug Discov Today; 2016 Sep; 21(9):1399-1411. PubMed ID: 27422270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
